Galleon Bio – Platform Topicals

Biopharmaceutical & Medical

Platform Drug Developer Targeting Neuropathic Pain & Inflammatory Skin Diseases

About Us

Shaping Health Through Innovation

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis
nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in voluptate velit esse cillum
fugiat nulla pariatur Excepteur sint occaecat cupidatat non proident.

Experienced

0 +

Caring for You, One Prescription at a Time

About Us

GalleonBio is led by a team of experienced biotech entrepreneurs and pharmaceutical industry professionals with a proven track record of successfully identifying & developing novel topical therapies that improve patient care and enhance their well-being.

Pipeline

We are currently developing a portfolio of therapeutic indications for radiodermatitis & CIPN (GB100), psoriasis (GB400), diabetic neuropathy (GB600), and neuropathic pain & inflammatory skin diseases (GB800) with a goal of demonstrating their efficacy and safety.

Technology

Revolutionizing Medicine with
Cutting-Edge Technology

Radiodermatitis

Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis eiusmod tempor incididunt ut labore et dolore magna aliqua.

Chemotherapy Induced Neuropathy

Psoriasis

casino50

Biopharmaceutical & Medical

Platform Drug Developer Targeting Neuropathic Pain & Inflammatory Skin Diseases

About Us

Shaping Health Through Innovation

Our Vision

Our Mission

Experienced

Owen Samuel

Caring for You, One Prescription at a Time

About Us

Pipeline

Technology

Quick Link

Information

Our Location

Social Media